Ipilimumab: an investigational immunotherapy for glioblastoma-Reference-Cited by-同舟云学术

Ipilimumab: an investigational immunotherapy for glioblastoma

Published:2020-10-06 Issue:11 Volume:29 Page:1187-1193
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Youssef Gilbert¹²,Dietrich Jorg¹²

Affiliation:

1. MGH Cancer Center, Massachusetts General Hospital & Harvard Medical School, Boston, MA, USA

2. Department of Neurology, Division of Neuro-Oncology, Massachusetts General Hospital & Harvard Medical School, Boston, MA, USA

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543784.2020.1826436

Reference66 articles.

1. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary

2. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012–2016 | Neuro-Oncology | Oxford Academic [Internet]. [cited 2020 Jun 6]. Available from: https://academic.oup.com/neuro-oncology/article/21/Supplement_5/v1/5610892

3. Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma

4. Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma

5. Survival Trends in Elderly Patients with Glioblastoma in the United States: a Population-based Study

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glioblastoma Tumor Microenvironment: An Important Modulator for Tumoral Progression and Therapy Resistance;Current Issues in Molecular Biology;2024-09-05

2. Harnessing the capacity of phytochemicals to enhance immune checkpoint inhibitor therapy of cancers: A focus on brain malignancies;Cancer Letters;2024-07

3. Immunotherapy for Brain Tumors: Where We Have Been, and Where Do We Go From Here?;Current Treatment Options in Oncology;2024-04-23

4. Insights into the glioblastoma tumor microenvironment: current and emerging therapeutic approaches;Frontiers in Pharmacology;2024-03-08

5. Aptamers combined with immune checkpoints for cancer detection and targeted therapy: A review;International Journal of Biological Macromolecules;2024-03